Katarzyna Dzitko
Lodz, LD, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Recombinant ROP8 antigen: diagnostics, immunogenicity, and therapeutic targeting in toxoplasmosis.
Journal: Frontiers in immunology
Published: December 16, 2025
Dermatophyte-Selective Imidazole-Thiosemicarbazides: Potent In Vitro Activity Against Trichophyton and Microsporum with No Anti-Candida Effect.
Journal: International journal of molecular sciences
Published: September 06, 2025
Lactic Acid Bacteria-Derived Postbiotics as Adjunctive Agents in Breast Cancer Treatment to Boost the Antineoplastic Effect of a Conventional Therapeutic Comprising Tamoxifen and a New Drug Candidate: An Aziridine-Hydrazide Hydrazone Derivative.
Journal: Molecules (Basel, Switzerland)
Published: February 19, 2024
The functional response of human monocyte-derived macrophages to serum amyloid A and Mycobacterium tuberculosis infection.
Journal: Frontiers in immunology
Published: June 10, 2023
Evaluation of long-term immunity and protection against T. gondii after immunization with multivalent recombinant chimeric T. gondii proteins.
Journal: Scientific reports
Published: March 07, 2023
TZD-Based Hybrid Molecules Act as Dual Anti-Mycobacterium tuberculosis and Anti-Toxoplasma gondii Agents.
Journal: International journal of molecular sciences
Published: December 05, 2022
Inhibition of Toxoplasma gondii by 1,2,4-triazole-based compounds: marked improvement in selectivity relative to the standard therapy pyrimethamine and sulfadiazine.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: September 27, 2022
4-Arylthiosemicarbazide derivatives - Pharmacokinetics, toxicity and anti-Toxoplasma gondii activity in vivo.
Journal: European journal of medicinal chemistry
Published: April 12, 2022
4-Arylthiosemicarbazide Derivatives as Toxoplasmic Aromatic Amino Acid Hydroxylase Inhibitors and Anti-inflammatory Agents.
Journal: International journal of molecular sciences
Published: February 23, 2022
4-Arylthiosemicarbazide derivatives as a new class of tyrosinase inhibitors and anti-Toxoplasma gondii agents.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: June 02, 2021
Last Updated: 09/26/2026